Product Code: GVR-4-68040-279-1
The global credentialing software and services in healthcare market size was valued at USD 900.0 million in 2025 and is projected to grow from USD 1000.0 million in 2026 to USD 1800.0 million by 2033, growing at a CAGR of 8.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 39.0% in 2025. The growth is attributed to the increasing awareness of the advantages of credentialing solutions, growing adoption of cloud-based solutions, rising technological advancements in healthcare IT infrastructure, and a growing number of strategic initiatives undertaken by the market players.
In March 2024, Noridian Healthcare Solutions, LLC, partnered with Acorn Credentialing to elevate health plans' provider enrollment and credentialing operations. Together, the companies accelerated onboarding processes and reduced operational bottlenecks caused by slow and inefficient workflows. Modern credentialing solutions automate primary source verification (PSV), payer enrollment, document management, and license monitoring, thereby significantly reducing manual intervention and administrative burden. For instance, AI-enabled credentialing platforms report reductions of up to 60% in credentialing-related administrative costs and can accelerate provider verification and onboarding processes by up to four times compared to traditional manual workflows.
Furthermore, automated credentialing systems help healthcare organizations minimize delays in provider enrollment, improve data accuracy, and shorten the time required for providers to begin billing. In addition, integration capabilities are becoming increasingly important across healthcare IT infrastructure, allowing different systems to communicate and share data seamlessly. Credentialing software that integrates with other healthcare systems, such as electronic health records (EHRs) and practice management systems, enhances interoperability and workflow efficiency.
Thus, prominent players in the market are focusing on advancements in integration capabilities. For example, Symplr is making advancements in its Connected Enterprise vision by integrating its SaaS solutions with a unified user interface, an API Gateway (featuring EHR integration), and a shared suite of platform services. This allows synchronized workflows across solutions.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Component
- 1.1.2. Functionality
- 1.1.3. Deployment type
- 1.1.4. End-use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline.
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Component outlook
- 2.2.2. Functionality outlook
- 2.2.3. Deployment type outlook
- 2.2.4. End-use outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Credentialing Software and Services in Healthcare Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Credentialing Software and Services in Healthcare Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & legal landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social & environmental landscape
- 3.3.2.4. Technological landscape
Chapter 4. Credentialing Software and Services in Healthcare Market: Component Estimates & Trend Analysis
- 4.1. Component Market Share, 2025 & 2033
- 4.2. Segment Dashboard
- 4.3. Global Credentialing Software and Services in Healthcare Market by Component Outlook
- 4.3.1. Software
- 4.3.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.3.2. Services
- 4.3.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 5. Credentialing Software and Services in Healthcare Market: Functionality Estimates & Trend Analysis
- 5.1. Functionality Market Share, 2025 & 2033
- 5.2. Segment Dashboard
- 5.3. Global Credentialing Software and Services in Healthcare Market by Functionality Outlook
- 5.3.1. Credentialing and Enrollment
- 5.3.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.3.2. Provider Information Management
- 5.3.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 6. Credentialing Software and Services in Healthcare Market: Deployment Type Estimates & Trend Analysis
- 6.1. Deployment Type Market Share, 2025 & 2033
- 6.2. Segment Dashboard
- 6.3. Global Credentialing Software and Services in Healthcare Market by Deployment Type Outlook
- 6.3.1. Cloud Based
- 6.3.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 6.3.2. On-Premise
- 6.3.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 7. Credentialing Software and Services in Healthcare Market: End-use Estimates & Trend Analysis
- 7.1. End-use Market Share, 2025 & 2033
- 7.2. Segment Dashboard
- 7.3. Global Credentialing Software and Services in Healthcare Market by End-use Outlook
- 7.3.1. Hospitals and Clinics
- 7.3.1.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 7.3.2. Healthcare Payers
- 7.3.2.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 7.3.3. Other End-use
- 7.3.3.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 8. Credentialing Software and Services in Healthcare Market: Regional Estimates & Trend Analysis, By Component, By Functionality, By Deployment Type, By End-use
- 8.1. Regional Market Share Analysis, 2025 & 2033
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
- 8.5. North America
- 8.5.1. U.S.
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory framework/ reimbursement structure
- 8.5.1.3. Competitive scenario
- 8.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.2. Canada
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework/ reimbursement structure
- 8.5.2.3. Competitive scenario
- 8.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6. Europe
- 8.6.1. UK
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory framework/ reimbursement structure
- 8.6.1.3. Competitive scenario
- 8.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.2. Germany
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory framework/ reimbursement structure
- 8.6.2.3. Competitive scenario
- 8.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.3. France
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Regulatory framework/ reimbursement structure
- 8.6.3.3. Competitive scenario
- 8.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.4. Italy
- 8.6.4.1. Key country dynamics
- 8.6.4.2. Regulatory framework/ reimbursement structure
- 8.6.4.3. Competitive scenario
- 8.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.5. Spain
- 8.6.5.1. Key country dynamics
- 8.6.5.2. Regulatory framework/ reimbursement structure
- 8.6.5.3. Competitive scenario
- 8.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.6. Denmark
- 8.6.6.1. Key country dynamics
- 8.6.6.2. Regulatory framework/ reimbursement structure
- 8.6.6.3. Competitive scenario
- 8.6.6.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.7. Sweden
- 8.6.7.1. Key country dynamics
- 8.6.7.2. Regulatory framework/ reimbursement structure
- 8.6.7.3. Competitive scenario
- 8.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.8. Norway
- 8.6.8.1. Key country dynamics
- 8.6.8.2. Regulatory framework/ reimbursement structure
- 8.6.8.3. Competitive scenario
- 8.6.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7. Asia Pacific
- 8.7.1. Japan
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory framework/ reimbursement structure
- 8.7.1.3. Competitive scenario
- 8.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.2. China
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory framework/ reimbursement structure
- 8.7.2.3. Competitive scenario
- 8.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.3. India
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Regulatory framework/ reimbursement structure
- 8.7.3.3. Competitive scenario
- 8.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.4. Australia
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Regulatory framework/ reimbursement structure
- 8.7.4.3. Competitive scenario
- 8.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.5. South Korea
- 8.7.5.1. Key country dynamics
- 8.7.5.2. Regulatory framework/ reimbursement structure
- 8.7.5.3. Competitive scenario
- 8.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.6. Thailand
- 8.7.6.1. Key country dynamics
- 8.7.6.2. Regulatory framework/ reimbursement structure
- 8.7.6.3. Competitive scenario
- 8.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8. Latin America
- 8.8.1. Brazil
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Regulatory framework/ reimbursement structure
- 8.8.1.3. Competitive scenario
- 8.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.2. Mexico
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Regulatory framework/ reimbursement structure
- 8.8.2.3. Competitive scenario
- 8.8.2.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.3. Argentina
- 8.8.3.1. Key country dynamics
- 8.8.3.2. Regulatory framework/ reimbursement structure
- 8.8.3.3. Competitive scenario
- 8.8.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9. MEA
- 8.9.1. South Africa
- 8.9.1.1. Key country dynamics
- 8.9.1.2. Regulatory framework/ reimbursement structure
- 8.9.1.3. Competitive scenario
- 8.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9.2. Saudi Arabia
- 8.9.2.1. Key country dynamics
- 8.9.2.2. Regulatory framework/ reimbursement structure
- 8.9.2.3. Competitive scenario
- 8.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9.3. UAE
- 8.9.3.1. Key country dynamics
- 8.9.3.2. Regulatory framework/ reimbursement structure
- 8.9.3.3. Competitive scenario
- 8.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 8.9.4. Kuwait
- 8.9.4.1. Key country dynamics
- 8.9.4.2. Regulatory framework/ reimbursement structure
- 8.9.4.3. Competitive scenario
- 8.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.2.1. Innovators
- 9.2.2. List of key distributors and channel partners
- 9.2.3. Key customers
- 9.2.4. Key company market share analysis, 2023
- 9.2.5. symplr
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. HealthStream
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. Bizmatics, Inc. (Constellation Software Inc.)
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. Naviant
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. OSP Labs
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives
- 9.2.10. Wybtrak, Inc.
- 9.2.10.1. Company overview
- 9.2.10.2. Financial performance
- 9.2.10.3. Product benchmarking
- 9.2.10.4. Strategic initiatives
- 9.2.11. Applied Statistics & Management, Inc.
- 9.2.11.1. Company overview
- 9.2.11.2. Financial performance
- 9.2.11.3. Product benchmarking
- 9.2.11.4. Strategic initiatives
- 9.2.12. 3WON
- 9.2.12.1. Company overview
- 9.2.12.2. Financial performance
- 9.2.12.3. Product benchmarking
- 9.2.12.4. Strategic initiatives
- 9.2.13. HCA Management Services, L.P.
- 9.2.13.1. Company overview
- 9.2.13.2. Financial performance
- 9.2.13.3. Product benchmarking
- 9.2.13.4. Strategic initiatives